CSIMarket



Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Operating Income Growth by Quarter and Year

Quest Diagnostics Inc's Operating Income results by quarter and year




DGX Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 536.00 795.00 363.00
III Quarter September - 652.00 718.00 313.00
II Quarter June - 533.00 283.00 307.00
I Quarter March 513.00 660.00 175.00 248.00
FY   513.00 2,381.00 1,971.00 1,231.00



DGX Operating Income first quarter 2022 Y/Y Growth Comment
Quest Diagnostics Inc reported decline in Operating Income in the first quarter 2022 by -22.27% to $ 513.00 millions, from the same quarter in 2021.
The contraction in the first quarter 2022 Quest Diagnostics Inc's Operating Income compares unfavorably to the Company's average Operating Income growth of 7.43%.

Among companies who have reported first quarter 2022 results in the Medical Laboratories industry only one Company has achieved higher year on year Operating Income results in the first quarter 2022. While Quest Diagnostics Inc' s Operating Income fall of -22.27% ranks overall at the positon no. 151 in the first quarter 2022.

Explain Operating Income growth


DGX Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -32.58 % 119.01 % -
III Quarter September - -9.19 % 129.39 % 2.96 %
II Quarter June - 88.34 % -7.82 % 0.66 %
I Quarter March -22.27 % 277.14 % -29.44 % -8.82 %
FY   - 20.8 % 60.11 % 410.79 %

Financial Statements
Quest Diagnostics Inc's first quarter 2022 Operating Income $ 513.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2021 Operating Income $ 660.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Operating Income Growth >>


DGX Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -17.79 % 10.72 % 15.97 %
III Quarter September - 22.33 % 153.71 % 1.95 %
II Quarter June - -19.24 % 61.71 % 23.79 %
I Quarter March -4.29 % -16.98 % -51.79 % -
FY (Year on Year)   - 20.8 % 60.11 % 410.79 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #5
Overall #151

Operating Income Y/Y Growth Statistics
High Average Low
439.91 % 7.43 % -82.06 %
(Dec 31 2019)   (Dec 31 2018)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #5
Overall #151
Operating Income Y/Y Growth Statistics
High Average Low
439.91 % 7.43 % -82.06 %
(Dec 31 2019)   (Dec 31 2018)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Quest Diagnostics Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
153.71 % 6.19 % -62.12 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Operating Income Comment
In the I. Quarter 2022 Quest Diagnostics Inc realized fall in Operating Income sequentially by -4.29% to $ 513.00 millions, from $ 536.00 millions achived a quarter before.

It's not huge problem, as I. Quarter Operating Income generally gravitate to dip in this quarter.

Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Operating Income growth. While Quest Diagnostics Inc's Operating Income growth quarter on quarter, overall rank is 96.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #3
Overall #96
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #1
Healthcare Sector #3
Overall #96
Operating Income Q/Q Growth Statistics
High Average Low
153.71 % 6.19 % -62.12 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Operating Income Comment
In the I. Quarter 2022 Quest Diagnostics Inc realized fall in Operating Income sequentially by -4.29% to $ 513.00 millions, from $ 536.00 millions released a quarter before.

If you analyse recent downturn at the I. Quarter, you should assume, that commonly I. Quarter 2022 results appear to be weaker relative to the quarter before, Elliot  Taylor, a business contributor said.

Within Medical Laboratories industry Quest Diagnostics Inc achieved highest sequential Operating Income growth. While Quest Diagnostics Inc's Operating Income growth quarter on quarter, overall rank is 96.


Quest Diagnostics Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 2,234.00 $ 2,381.00 $ 2,640.00 $ 2,706.00 $ 2,456.00
Y / Y Operating Income Growth (TTM) -9.04 % 20.8 % 71.54 % 138.62 % 112.09 %
Year on Year Operating Income Growth Overall Ranking # 133 # 1245 # 671 # 25 # 999
Seqeuential Operating Income Change (TTM) -6.17 % -9.81 % -2.44 % 10.18 % 24.61 %
Seq. Operating Income Growth (TTM) Overall Ranking # 151 # 1987 # 1860 # 1271 # 31




Cumulative Operating Income growth Comment
For the 12 months ended Mar 31 2022 Quest Diagnostics Inc reported a decrease in Operating Income by -9.04% year on year, to $2,234 millions, compare to the 20.8% growth at Dec 31 2021.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 133, from total ranking in previous quarter at 1245.

Operating Income TTM Q/Q Growth Statistics
High Average Low
439.91 %
7.43 %
-82.06 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 3
Overall # 133

Operating Income TTM Y/Y Growth Statistics
High Average Low
575 %
31.89 %
-82.51 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 5
S&P 500 # 151
Cumulative Operating Income growth Comment
For the 12 months ended Mar 31 2022 Quest Diagnostics Inc reported a decrease in Operating Income by -9.04% year on year, to $2,234 millions, compare to the 20.8% growth at Dec 31 2021.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 133, from total ranking in previous quarter at 1245.

Operating Income TTM Q/Q Growth Statistics
High Average Low
439.91 %
7.43 %
-82.06 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 3
Overall # 133

Operating Income TTM Y/Y Growth Statistics
High Average Low
575 %
31.89 %
-82.51 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 5
S&P 500 # 151




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
DGX's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for DGX's Competitors
Operating Income Growth for Quest Diagnostics Inc's Suppliers
Operating Income Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Operating Income decrease for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Lemaitre Vascular Inc-0.21%$ -0.214 millions
Intuitive Surgical Inc -2.09%$ -2.087 millions
Innoviva Inc -2.21%$ -2.207 millions
Stryker Corp-2.61%$ -2.614 millions
National Research Corporation-2.69%$ -2.687 millions
Diffusion Pharmaceuticals Inc -2.77%$ -2.773 millions
Msa Safety Inc-3.11%$ -3.111 millions
Nuvasive Inc-3.28%$ -3.282 millions
Royalty Pharma Plc-4.18%$ -4.178 millions
Phibro Animal Health Corp-4.66%$ -4.659 millions
Co diagnostics Inc -4.94%$ -4.942 millions
National Healthcare Corp-6.60%$ -6.602 millions
Natus Medical Inc-7.50%$ -7.500 millions
Dexcom Inc -10.02%$ -10.022 millions
Biomx Inc -10.20%$ -10.196 millions
Pacira Biosciences inc -10.52%$ -10.516 millions
Align Technology inc -12.14%$ -12.138 millions
Lifevantage Corp-12.60%$ -12.596 millions
Tivity Health Inc -12.86%$ -12.858 millions
Rackspace Technology Inc -13.64%$ -13.636 millions
Diversified Healthcare Trust-15.19%$ -15.194 millions
Community Health Systems Inc -17.18%$ -17.178 millions
Fonar Corporation-18.88%$ -18.878 millions
Universal Health Services Inc -21.24%$ -21.244 millions
Molecular Templates Inc -21.64%$ -21.642 millions
Quest Diagnostics Inc-22.27%$ -22.273 millions
Davita Inc -23.56%$ -23.564 millions
Fulgent Genetics Inc -24.35%$ -24.348 millions
Zimmer Biomet Holdings Inc -25.30%$ -25.301 millions
Reynolds Consumer Products Inc -25.44%$ -25.439 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IMAB's Profile

Stock Price

IMAB's Financials

Business Description

Fundamentals

Charts & Quotes

IMAB's News

Suppliers

IMAB's Competitors

Customers & Markets

Economic Indicators

IMAB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071